Navigation Links
Eastern Clinical Trials Russia-CEE Joins BIOCOM CRO
Date:5/1/2013

Moscow, Russia (PRWEB) May 01, 2013

Eastern Clinical Trials (ECT), a contract research organization (CRO) with operations in Russia, Central and Eastern Europe, is pleased to announce that ECT has joined BIOCOM CRO. BIOCOM CRO is a newly created Initiative by BIOCOM (San Diego) the largest regional life science association in the world.     "We are proud to become a member of BIOCOM CRO, a network consisting of the most reputable Life Science Companies and CROs in the Southern California region", said Dr. Svetlana Vodolazhskaya, ECT's Managing Director. "We look forward to being actively involved in the strategy and direction of the rapidly expanding Clinical Research outsourcing community in connecting clinical research programs on a global basis".

Representing Eastern Clinical Trials on BIOCOM CRO advisory committee is Jack Florio, ECT’s representative in the San Diego office. Jack can be reached at jack(dot)florio(at)easterntrials(dot)com
or +1 (858) 864-4339.

About Eastern Clinical Trials (ECT http://www.easterntrials.com)
Established in 2004, Eastern Clinical Trials (ECT) has grown from a local Moscow-based CRO to a trusted regional partner in clinical research with operations in Russia, Ukraine, Belarus, Georgia, Hungary and Slovakia. ECT provides a full spectrum of clinical trial services including project management, monitoring, study feasibility, regulatory submission and support, translation, safety reporting and warehousing.

About BIOCOM CRO (http://www.biocomcro.org )
BIOCOM CRO is an initiative created by BIOCOM, the world’s largest life science association with 550 members in the Southern California region.

ECT Contact:
Svetlana Vodolazhskaya, MD
Managing Director
Russia 119034 Moscow
Tel: + 7(925)5023189
svetlana(dot)vodolazhskaya(at)easterntrials(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10681667.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
2. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”
3. Eastern Clinical Trials Russia CRO Passes EMA Inspection
4. Aviir Signs Distribution and Expansion Pact Covering 19 Middle Eastern and North African Countries
5. Aviir Signs Distribution And Expansion Pact Covering 19 Middle Eastern And North African Countries
6. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
7. Positive Clinical Study Results for BSPs HyperQ Technology
8. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
9. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
10. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
11. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ... , ... The Conference Forum and The Trout Group ... of upcoming panels and events. The partnership culminates with the 4th Annual IO360° ... York City. , “With our experience in producing the Immuno-Oncology 360° NYC event and ...
(Date:8/14/2017)... ... August 14, 2017 , ... Every year, millions of dollars ... antibody community have recently come together to address this antibody crisis and develop ... , The team at Thermo Fisher Scientific has arranged for ...
(Date:8/11/2017)... Md. , Aug. 11, 2017 /PRNewswire/ ... a New York Times article regarding the ... billion, according to Kalorama Information.  The article, ... App for That"  used information from ... Patient Monitoring & Telemedicine Market  (Sleep, Diabetes, ...
(Date:8/11/2017)... ... 11, 2017 , ... “There is an increasing consumer call ... synthetic ingredients,” said Matt Hundt, President of Third Wave Bioactives. “Combining the strong ... know-how of Biorigin will allow us to bring truly novel fermented ingredient technologies ...
Breaking Biology Technology:
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
Breaking Biology News(10 mins):